MediciNova US patent for method of treating progressive MS

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

MediciNova US patent for method of treating progressive MS

Post by MSUK »

Image


MediciNova Inc, a biopharmaceutical company, has received a Notice of Allowance from the US Patent and Trademark Office for a pending patent application, which covers the use of ibudilast for the treatment of progressive forms of multiple sclerosis.

Ibudilast (MN-166), is the company's lead drug development candidate for certain neurological conditions, including progressive multiple sclerosis, neuropathic pain, and drug addiction.

A patent maturing from this allowed patent application is expected to expire no earlier than early 2029 and covers a method of treating primary progressive multiple sclerosis (PPMS) or secondary progressive MS (SPMS) by administering ibudilast either alone or in combination with other drugs....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1311
MS-UK - http://www.ms-uk.org/
User avatar
NHE
Volunteer Moderator
Posts: 6416
Joined: Sat Nov 20, 2004 3:00 pm
Contact:

Re: MediciNova US patent for method of treating progressive

Post by NHE »

More info on ibudilast from MediciNova...

http://www.medicinova.com/html/research ... etoverview

also...

http://www.chemicalbook.com/ProductChem ... 945_EN.htm
Phosphodiesterase inhibitor (IC 50 values are 53, 35, 48, 12 and 10 mM for PDE Ia, II, III, IV and V respectively). Inhibits platelet aggregation and is an orally-active cerebral vasodilator, bronchodilator and antiallergic agent.
also...

About 111 articles on ibudilast listed on Pubmed (should make for some interesting reading).

http://www.ncbi.nlm.nih.gov/pubmed?term=ibudilast


NHE
Post Reply

Return to “General Discussion”